Enanta Pharmaceuticals shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Enanta Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Enanta Pharmaceuticals held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enanta Pharmaceuticals by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $304k | 32k | 9.41 |
| 2023-09-30 | $363k | 33k | 11.17 |
| 2023-06-30 | $1.4M | 65k | 21.40 |
| 2023-03-31 | $2.6M | 64k | 40.45 |
| 2022-12-31 | $2.8M | 60k | 46.52 |
| 2022-09-30 | $3.1M | 60k | 51.86 |
| 2022-06-30 | $2.6M | 56k | 47.28 |
| 2022-03-31 | $3.8M | 54k | 71.18 |
| 2021-12-31 | $4.0M | 54k | 74.77 |
| 2021-09-30 | $3.1M | 55k | 56.82 |
| 2021-06-30 | $2.7M | 62k | 44.02 |
| 2021-03-31 | $3.3M | 66k | 49.32 |
| 2020-12-31 | $2.7M | 65k | 42.10 |
| 2020-09-30 | $2.7M | 60k | 45.79 |
| 2020-06-30 | $3.1M | 62k | 50.21 |
| 2020-03-31 | $3.0M | 58k | 51.43 |
| 2019-12-31 | $3.3M | 54k | 61.78 |
| 2019-09-30 | $3.1M | 51k | 60.07 |
| 2019-06-30 | $4.2M | 50k | 84.39 |
| 2019-03-31 | $4.5M | 47k | 95.53 |
| 2018-12-31 | $3.3M | 47k | 70.84 |
| 2018-09-30 | $3.3M | 38k | 85.46 |
| 2018-06-30 | $4.4M | 38k | 115.90 |
| 2018-03-31 | $3.0M | 37k | 80.90 |
| 2017-12-31 | $2.1M | 37k | 58.67 |
| 2017-09-30 | $1.5M | 32k | 46.81 |
| 2017-06-30 | $1.1M | 31k | 35.98 |
| 2017-03-31 | $964k | 31k | 30.79 |
| 2016-12-31 | $788k | 24k | 33.50 |
| 2016-09-30 | $673k | 25k | 26.60 |
| 2016-06-30 | $537k | 24k | 22.06 |
| 2016-03-31 | $539k | 18k | 29.35 |
| 2015-12-31 | $603k | 18k | 33.03 |
| 2015-09-30 | $605k | 17k | 36.16 |
| 2015-06-30 | $659k | 15k | 44.97 |
| 2015-03-31 | $307k | 10k | 30.66 |
| 2014-12-31 | $418k | 8.2k | 50.89 |
| 2014-09-30 | $343k | 8.7k | 39.59 |
| 2014-06-30 | $396k | 9.2k | 43.03 |